Recordkeeping and Reporting Requirements for Drug Products Containing Gamma-Hydroxybutyric Acid (GHB)
other · Proposed Rule · Notice of proposed rulemaking. · Published 2003-11-25 · 68 FR 66048
Document
Document number
03-29336
Federal Register citation
68 FR 66048
Type
Proposed Rule
Action
Notice of proposed rulemaking.
Category
other
Publication date
2003-11-25
Abstract
DEA proposes to amend its regulations to require additional recordkeeping and reporting requirements for drug products containing gamma-hydroxybutyric acid (GHB) for which an application has been approved under the Federal Food, Drug, and Cosmetic Act. DEA proposes these changes pursuant to section 4 of the "Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000." These additional requirements are necessary to protect against the diversion of GHB for illicit purposes.